|
Pharmacological Group: Antineoplastics, Active Ingredient: Cetuximab, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 5, Unit: Mg/Ml, Volume: 20 Ml, Presentation: Ampoule Vial, Accessory: N/A, Volume: 100 Ml, Active Ingredient: Dasatinib, Pharmaceutical Form: Coated Tablet, Concentration / Dosage: 100, Unit: Mg, Volume: N/A, Presentation: N/A, Supply Form: Unit, Concentration / Dosage: 20, Active Ingredient: Gefitinib, Concentration / Dosage: 250, 03/18/2026 - 14:22:44, Pharmacological Group: Hormones That Act On The Genito-Urinary System, Active Ingredient: Goserelin Acetate, Concentration/Dosage: 10.8, Volume: Not Applicable, Presentation: Prefilled Syringe, Accessory: Not Applicable, Active Ingredient: Ibrutinib, Pharmaceutical Form: Hard Gelatin Capsule, Concentration/Dosage: 140, Presentation: Blister, Active Ingredient: Nilotinib, Pharmaceutical Form: Capsule, Concentration / Dosage: 200, Active Ingredient: Sorafenib Tosylate, Presentation: Not Applicable, Active Ingredient: Sunitinib Malate, Concentration / Dosage: 50, Active Ingredient: Vinorelbine Tartrate, Concentration / Dosage: 30
|
